| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S12032-011-0098-3 |
| P698 | PubMed publication ID | 22048943 |
| P50 | author | Bassim Jaffar Al Bahrani | Q64379866 |
| P2093 | author name string | S Kumar | |
| S Kuruvila | |||
| S M El-Sayed | |||
| F A R Al-Lawati | |||
| K Al-Mawaly | |||
| M S Al-Moundhri | |||
| A Al-Hamdani | |||
| G Bhatnager | |||
| I Al-Hadabi | |||
| P2860 | cites work | Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 | Q27860674 |
| Immunohistochemical expression of the cyclooxygenase-2 (COX-2) in gastric cancer. The correlations with the tumor angiogenesis and patients' survival. | Q33364994 | ||
| COX-2 activation is associated with Akt phosphorylation and poor survival in ER-negative, HER2-positive breast cancer | Q33747000 | ||
| Clinicopathological significance of platelet-derived growth factor (PDGF)-B and vascular endothelial growth factor-A expression, PDGF receptor-β phosphorylation, and microvessel density in gastric cancer | Q33759177 | ||
| Cyclooxygenase-deficient mice. A summary of their characteristics and susceptibilities to inflammation and carcinogenesis | Q33834295 | ||
| Microvessel density is a prognostic marker of human gastric cancer | Q33868722 | ||
| Eicosanoids and cancer | Q33966203 | ||
| Regulation of tumor angiogenesis by dietary fatty acids and eicosanoids | Q34120858 | ||
| ZD1839 (Iressa) induces antiangiogenic effects through inhibition of epidermal growth factor receptor tyrosine kinase. | Q34125874 | ||
| Betacellulin induces angiogenesis through activation of mitogen-activated protein kinase and phosphatidylinositol 3'-kinase in endothelial cell | Q34163809 | ||
| EGFR and cancer prognosis | Q34399312 | ||
| Review: molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis. | Q34425964 | ||
| Interaction between the epidermal growth factor receptor (EGFR) and the vascular endothelial growth factor (VEGF) pathways: a rational approach for multi-target anticancer therapy | Q34535769 | ||
| Epidemiology of gastric cancer in Japan | Q34559042 | ||
| Clinical significance of angiogenesis in gastrointestinal cancers: a target for novel prognostic and therapeutic approaches | Q35165648 | ||
| MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer | Q35770018 | ||
| Prognostic significance of expression of cyclooxygenase-2 and vascular endothelial growth factor in human gastric carcinoma | Q36190616 | ||
| Epidermal growth factor receptor (EGFR) signaling in cancer | Q36353031 | ||
| Has Cox-2 a prognostic role in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival results | Q36512153 | ||
| Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survival | Q36649103 | ||
| Molecular epidemiology of gastric cancer: current status and future prospects. | Q37076519 | ||
| Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival | Q37123491 | ||
| Nonsteroidal antiinflammatory drugs and risk of gastric adenocarcinoma: the multiethnic cohort study | Q37305861 | ||
| Molecular epidemiology of genetic susceptibility to gastric cancer: focus on single nucleotide polymorphisms in gastric carcinogenesis | Q37646140 | ||
| Activation of epidermal growth factor receptor signaling by the prostaglandin E(2) receptor EP4 pathway during gastric tumorigenesis | Q38338269 | ||
| Histopathological subclassification of triple negative breast cancer using prognostic scoring system: five variables as candidates | Q38413575 | ||
| Expression of betacellulin and epidermal growth factor receptor in hepatocellular carcinoma: implications for angiogenesis | Q38508912 | ||
| Prognostic significance of cyclooxygenase-2 in laryngeal squamous cell carcinoma | Q40773450 | ||
| COX-2 expression in gastric cancer and its relationship with angiogenesis using tissue microarray | Q42026137 | ||
| Anti-EGFR-Targeted Therapy for Esophageal and Gastric Cancers: An Evolving Concept | Q42119902 | ||
| Expression of CD34 in gastric cancer and its correlation with histology, stage, proliferation activity, p53 expression and apoptotic index | Q43678966 | ||
| Spatiotemporal expression of angiogenesis growth factor receptors during the revascularization of regenerating rat liver | Q43814814 | ||
| Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus | Q44587370 | ||
| Epidermal growth factor receptor in meningiomas is expressed predominantly on endothelial cells | Q46137374 | ||
| Clinicopathologic significance of cyclooxygenase-2 overexpression in esophageal squamous cell carcinoma | Q47637474 | ||
| Assessing microvessel density in gastric carcinoma: a comparison of three markers. | Q48006544 | ||
| Increased abundance of cyclooxygenase-2 correlates with vascular endothelial growth factor-A abundance and tumor angiogenesis in gastric cancer. | Q54771331 | ||
| Molecular Epidemiology of Gastric Cancer | Q61945692 | ||
| Expression of cyclooxygenase-2 in human gastric carcinoma | Q73221180 | ||
| Tumor angiogenesis related to growth pattern and lymph node metastasis in early gastric cancer | Q73660713 | ||
| Amplification of the c-met, c-erbB-2 and epidermal growth factor receptor gene in human gastric cancers: correlation to clinical features | Q77223135 | ||
| Immunohistochemical demonstration of angiogenic growth factors and EGF receptor in hepatic metastases and primary human gastric cancer | Q77533104 | ||
| Angiogenesis as an unfavorable factor related to lymph node metastasis in early gastric cancer | Q77608282 | ||
| Correlation of COX-2 and K-ras expression to clinical outcome in gastric cancer | Q79374360 | ||
| EGFR and gastrointestinal stromal tumor: an immunohistochemical and FISH study of 82 cases | Q80647736 | ||
| Concomitant overexpression of cyclooxygenase-2 in HER-2-positive on Smad4-reduced human gastric carcinomas is associated with a poor patient outcome | Q80901424 | ||
| Immunohistochemical evaluation of the tumor neoangiogenesis as a prognostic factor for gastric cancers | Q81369318 | ||
| Early-onset gastric cancers have a different molecular expression profile than conventional gastric cancers | Q82536201 | ||
| COX-2 and preoperative CA-125 level are strongly correlated with survival and clinical responsiveness to chemotherapy in ovarian cancer | Q83151215 | ||
| Retrospective study of capecitabine and celecoxib in metastatic colorectal cancer: potential benefits and COX-2 as the common mediator in pain, toxicities and survival? | Q83930943 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 1739-1747 | |
| P577 | publication date | 2011-11-03 | |
| P1433 | published in | Medical Oncology | Q2152666 |
| P1476 | title | Prognostic significance of cyclooxygenase-2, epidermal growth factor receptor 1, and microvascular density in gastric cancer | |
| P478 | volume | 29 |
| Q37164615 | C5b-9 Staining Correlates With Clinical and Tumor Stage in Gastric Adenocarcinoma |
| Q42177754 | Calpain-1 Expression in Triple-Negative Breast Cancer: A Potential Prognostic Factor Independent of the Proliferative/Apoptotic Index. |
| Q40332121 | Clinicopathologic and prognostic significance of human epidermal growth factor receptor in patients with gastric cancer: An updated meta-analysis |
| Q54458754 | Clinicopathologic characteristics of YES-associated protein 1 overexpression and its relationship to tumor biomarkers in gastric cancer. |
| Q38157778 | Cyclooxygenase-2 expression is associated with poor overall survival of patients with gastric cancer: a meta-analysis |
| Q40794203 | Expression and clinical significance of cyclooxygenase-2 and interleukin-32 in primary gastric B-cell lymphoma |
| Q92991368 | Interplay between STAT3, Cell Adhesion Molecules and Angiogenesis-Related Parameters in Gastric Carcinoma. Does STAT3 Really Have a Prognostic Value? |
| Q59075723 | Neoadjuvant chemotherapy with FOLFOX4 regimen to treat advanced gastric cancer improves survival without increasing adverse events: a retrospective cohort study from a Chinese center |
| Q38164703 | Role of cyclooxygenase-2 in gastric cancer development and progression |
Search more.